Abstract: Fasudil, a potent Rho kinase (ROCK) inhibitor, can ameliorate LPS-induced acute lung injury (ALI) in mice, but the mechanism remains obscure. In this study, a mice model of ALI was established by intra-tracheal instillation of LPS.
Introduction
Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS), induced by various infectious and noninfectious insults with a complex pathogenesis, is a fatal clinical syndrome with high morbidity and mortality in critically ill patients [1] . It is generally accepted that ALI involves inflammation injury to the alveolar-capillary barrier, resulting in increased lung permeability, accumulation of protein-rich pulmonary edema fluid, neutrophil entrapment and activation in the airspaces [1] [2] [3] .
These pathological abnormalities lead to deficient gas exchange, arterial hypoxemia, and respiratory failure that define clinical ALI.
In the inner walls of pulmonary capillary, neighboring endothelial cells are tightly connected to each other by intercellular junctions, constituting a continuous endothelial cell monolayer, one semi-permeable barrier between blood and interstitium [4] . Under normal physiologic conditions, this endothelial monolayer maintains the homeostasis of lung interstitial fluid through dynamically controlling the transcellular extravasation of cells, proteins, and fluids [5] . However, as the primary target of inflammation, endothelia is vulnerable to damaging insults, such as pneumonia and sepsis that invade via the alveolar or vascular lumen. Bacterial toxins rapidly compromise endothelial cell function, leading to disruption of endothelial barrier integrity and subsequent pulmonary hyperpermeability [6, 7] . Based on these facts, it is reasonable that protecting endothelial function could be a novel therapeutic strategy [2] . However, no specific pharmacologic therapy to date is available to improve endothelial function in the treatment of ALI.
ROCK, a serine/threonine kinase, is a downstream effector of Rho family small GTPases. Mounting evidence has shown that ROCKs act as determinant molecular switches controlling several critical cellular functions, such as proliferation and apoptosis, cytoskeletal rearrangement, cell adhesion and migration, inflammation, and reactive oxygen species formation [8] [9] [10] . Fasudil, a potent and selective ROCK inhibitor, showed clinical effectiveness and safety in the treatments of cardiovascular and cerebrovascular diseases, such as aneurysmal subarachnoid hemorrhage and myocardial ischemia [11, 12] . Some experimental and clinical studies on respiratory diseases have shown that fasudil would be a prospective drug for the treatment of pulmonary fibrosis [13] and pulmonary arterial hypertension [14] [15] [16] . Moreover, it was reported that fasudil prevented sepsis-induced ALI by inhibiting system inflammation in vivo [17] and lipopolysaccharide (LPS)-induced apoptosis of rat PMECs in vitro [18] . However, the effects of fasudil on LPS-induced ALI and the underlying mechanisms remain poorly understood.
In the present study, a murine model of ALI induced by intra-tracheal instillation of LPS and cultured human PMECs were used to investigate the protective effects of fasudil and its potential cellular and molecular mechanisms underlying.
Results

Fasudil inhibited LPS-induced Rho/ROCK activation in lung
Lung tissues of mice were harvested to investigate the effects of LPS and fasudil on ROCK activation. The expressions of ROCK isoforms (ROCK1 and ROCK2) and activation of downstream myosin phosphatase target (MYPT)-1 were examined by western blotting. We showed that LPS challenge led to a significant up-regulation of phosphorylated MYPT-1 (p-MYPT1) and ROCK1 in lungs (Figure 1 ). However, these effects of LPS were significantly inhibited by pretreatment with 10 mg/kg fasudil.
Fasudil ameliorated LPS-induced ALI and inflammation
To characterize the role of fasudil in LPS-mediated lung injury, lung histological changes were analyzed by an established scoring system [19] . Briefly, lung injury scores are positively correlated with alveolar septal congestion, alveolar hemorrhage, intra-alveolar fibrin deposition, and intra-alveolar infiltrates, which means a higher score represents more serious lung injury. As indicated in Figure 2A , compared with control mice, intra-tracheal instillation of LPS resulted in significant lung injury, which was alleviated by fasudil pretreatment.
Immunohistochemistry staining of Gr-1, a marker of mature neutrophil, showed that LPS-induced neutrophil infiltration in lung interstitium and alveolar space was markedly attenuated by fasudil pretreatment ( Figure 2B ). This result was further validated by measuring the neutrophil numbers and MPO activities in BALF. As shown in Figure 2C and D, fasudil reversed LPS-induced increments of neutrophil numbers and MPO activities in BALF.
TNF-α and IL-6 were measured to investigated the inflammatory response in lungs of mice. As indicated in Fig. 2E~H , fasudil pretreatment significantly decreased LPS-induced high levels of TNF-α and IL-6 either in serum or in lung homogenates.
Fasudil reduced lung hyperpermeability induced by LPS
Lung hyperpermeability is a hallmark of ALI. Therefore, the protein level in BALF was measured to analyze the severity of lung permeability. As shown in Figure   3A , pretreatment of fasudil significantly inhibited the increase of protein level in BALF after LPS administration.
We further evaluated lung permeability by injecting EB intraperitoneally. As shown in Figure 3C , LPS markedly increased lung vascular leakage as indicated by the elevated level of EB in lungs, while it was reversed by pretreatment with fasudil.
Fasudil protected lung endothelial cells against LPS-induced dysfunction in vivo
PMECs dysfunction brings about the collapse of endothelial barrier, and subsequent lung hyperpermeability [20] . Therefore, we first examined endothelial cell apoptosis using TUNEL and CD31 immunofluorescence staining. As shown in Figure   4A Figure 4B , western blot analysis demonstrated a significant down-regulation of VE-cadherin in the lungs of LPS-challenged mice. Although fasudil itself had no effect on the expression of VE-cadherin, it partially reversed LPS-induced down-regulation of VE-cadherin in the lungs of mice.
Together, these results strongly suggested that fasudil could attenuate LPS-induced ALI by protecting endothelial cells. Thus, in vitro studies were carried out to further evaluate the effect of fasudil on LPS-challenged human PMECs.
Fasudil reversed LPS-induced cultured human PMECs apoptosis
As indicated in Figure 5A , apoptotic nuclei with chromatin condensation and nuclear fragmentation were more easily to be dyed, and showed brilliant blue fluorescence, while non-apoptotic nuclei showed light blue fluorescence. Statistical analysis demonstrated that fasudil itself did not trigger PMECs apoptosis, but it reversed LPS-induced human PMECs apoptosis. To further confirm this finding, the activation of caspase-3, one critical executioner of apoptosis, was examined. Similarly, fasudil pretreatment potently inhibited LPS-induced caspase-3 cleavage/activation in human PMECs ( Figure 5B ).
Fasudil recovered LPS-induced human PMECs hyperpermeability
In a transwell system, FITC-dextran permeating through the monolayer of Figure 7A ). However, the trans-filter migration of neutrophils was significantly inhibited when LPS-stimulated human PMECs were pretreated with fasudil in the lower chamber.
Since activated human PMECs could synthesize and release chemokines to facilitate neutrophil migration, the expressions of CXCL-1, CXCL-2 and CXCL-8 by human PMECs were detected. qRT-PCR analysis showed LPS induced significant transcription of all these three chemokines in human PMECs ( Figure 7B ), which was attenuated by fasudil. Consistently, ELISA confirmed that fasudil significantly inhibited LPS-induced CXCL8 protein releasing from human PMECs ( Figure 7C ).
Neutrophil-endothelial adhesion is a critical step in the development of inflammatory diseases [21, 22] . Thus, neutrophils and human PMECs were cocultured to investigate the effect of fasudil on LPS-induced neutrophil-endothelial adhesion.
As indicated in Figure 7D , LPS significantly promoted neutrophil-endothelial adhesion, which was attenuated by fasudil pretreatment.
Neutrophil-endothelial adhesion is mediated by several adhesion molecules, especially intercellular adhesion molecule-1 (ICAM-1). Western blot analysis showed that fasudil completely reversed LPS-induced overexpression of ICAM-1 in human PMECs ( Figure 7E ).
Fasudil inhibited Rho/ROCK, NF-κB, and p38 MAPK activation in LPS-challenged HPMECs
To reveal the molecular mechanism for the protective effects of fasudil in endothelial dysfunction, ROCK, NF-κB, and MAPK signals involving the regulation of cell permeability, apoptosis, and inflammation were examined. Our results showed LPS induced rapid MYPT-1 phosphorylation at 30 min, and led to overexpression of ROCK1/ROCK2 at 24 h ( Figure 8A ). However, LPS-stimulated ROCK activation was completely suppressed by fasudil pretreatment.
As to NF-κB signaling, the phosphorylation of p65 and iκκαβ were significantly enhanced in LPS-challenged human PMECs ( Figure 8B ), which were reversed or suppressed by the pretreatment of fasudil. Moreover, immunofluorescence staining showed that fasudil pretreatment significantly inhibited NF-κB p65 nuclear translocation induced by LPS ( Figure 8C ).
For MAPK signaling, as shown in Fig. 8D , LPS triggered significant phosphorylation of p38 and JNK, and moderate phosphorylation of ERK in human PMECs. Interestingly, fasudil completely reversed LPS-elicited p38 phosphorylation, but neither JNK nor ERK phosphorylation.
Discussion
As the hallmark of ALI, lung vascular hyperpermeability is caused by endothelial dysfunction, which in turn results in pulmonary oedema and inappropriate accumulation of activated leukocytes in the interstitium and alveolar space. Exposure of the lower respiratory tract to LPS by intra-tracheal instillation is a well-documented animal model of ALI, which mimics pathological aspects of clinical development of ALI induced by pulmonary inflammation without causing systemic inflammation and multi-organ failure [23, 24] . In this study, our results suggest that fasudil, a potent ROCK inhibitor, inhibits LPS-induced ALI by preventing LPS-induced endothelial dysfunction via the following mechanisms: 1) protecting endothelial cells from LPS-induced apoptosis; 2) restoring endothelial barrier integrity and decreasing endothelial permeability; and 3) reducing endothelial inflammation.
The microvascular endothelium is the first barrier to be encountered by fluid or inflammatory cells tracking from vasculature to alveoli in the development of ALI.
PMECs are elementary components of lung microvascular that control the function of capillary membrane barrier under both physiological and pathological conditions. Death of PMECs causing loss of lung endothelium integrity has been proposed as an important mechanism for septic lung microvascular dysfunction [1] . Mounting evidence demonstrated that PMECs were highly vulnerable to apoptosis induced by detrimental stimuli such as LPS, TNF-α, and oxidative stress either in vitro or in vivo.
Recently, it was confirmed that apoptosis-mediated death of PMECs contributed to pulmonary microvascular barrier dysfunction in murine models of sepsis-induced ALI [25] . In the present study, we showed that fasudil protected pulmonary endothelial cells against LPS-induced apoptosis both in vivo and in vitro. Moreover, in cultured human PMECs, fasudil sufficiently inhibited LPS-induced activation of apoptosis executor caspase-3, accompanied by ROCK activation. Inhibition of the ROCK pathway by fasudil has been reported to prevent apoptosis through direct or indirect inhibition of caspase-3 [26, 27] . Previous studies have suggested that ROCK activation evoked caspase-3 cleavage via up-regulating the expression of Bax and Bclxl [28] and depending on myosin-mediated contraction [29] in different cell types. Although the mechanism by which inhibition of ROCK affects caspase-3 activation remains unclear, our results indicate that ROCK activation may act as an upstream event required for caspase-3 cleavage in LPS-induced human PMECs apoptosis.
Besides endothelial apoptosis mediated loss of endothelial barrier integrity, disruption of endothelial cell-cell adhesion also leads to microvascular hyperpermeability during ALI. It is now well recognized that loss of endothelial cell-cell adhesion is sufficient to induce the formation of inter-endothelial cell gap which provide paracellular pathway for free passage of macromolecules through the endothelial barrier [30, 31] . Several types of cellular junctions, such as tight junctions (TJs), adherens junctions (AJs) and gap junctions, participate in inter-endothelial adhesion. Among these junctions, TJs and AJs are implicated to be involved in the regulation of paracellular permeability. In our in vitro study, fasudil significantly decreased LPS-induced FITC-dextran leakage through the monolayer of cultured human PMECs in a transwell system, indicating that fasudil could alleviate endothelial paracellular hyperpermeability under endotoxin stress. Furthermore, western blot and immunofluorescence analysis showed that fasudil reversed the down-regulation of ZO-1 and VE-cadherin induced by LPS in human PMECs. Thus, these results suggest that fasudil could maintain the barrier function of endothelial cells by restoring inter-endothelial TJs and AJs. Recently, it was reported that LPS induced the redistribution and loss of VE-cadherin in human lung microvascular endothelial cells via Rho/ROCK signaling pathway [32] . Moreover, in the past decade, accumulating evidence has indicated that Rho/ROCK activation by different insults resulted in disarrangement and down-regulation of both VE-cadherin and ZO-1 in endothelial cells of brains [33] , intestines [34] or umbilical veins [35] , which may be attributed to the formation of actin stress fiber that is responsible for actomyosin cell contractility [35] . Thereby, maintaining inter-endothelial junctions by inhibiting ROCK activation could occupy a central position in decreasing the endothelial paracellular permeability in ALI.
Overwhelming inflammation characterized by massive inflammatory cells infiltration and mediators release is another feature of ALI. Endothelia is also a principle component involved in systemic or multiple organic inflammation. Under normal conditions, quiescent endothelial cells regulate inflammatory processes in blood vessels to very low levels, owing to the expression of anti-inflammatory molecules [36] . However, in response to noxious stimuli (such as bacterial endotoxins, persistent hypoxia, and ischemia), endothelial cells transform into pro-inflammatory phenotypes subsequently to release cytokines/chemokines and recruit leucocytes to the site of tissue injury or infection [37] . In our in vivo study, fasudil significantly decreased the levels of cytokines (TNF-α and IL-6) and reduced neutrophil exudation in lungs of LPS-treated mice, indicating that fasudil could effectively inhibit LPS-challenged inflammatory cells infiltration and subsequent lung injury. During the development of ALI, endothelial cells can be induced to express chemokines and adhesion molecules mediating neutrophils attachment on and migration through endothelium into lung parenchyma. Chemokines are the largest family of cytokines including four canonical subclasses, being CC, CXC, and CX3C, XC [38] . Among them, CXC chemokines exert most potent neutrophil chemotactic and activating properties both in vitro and in vivo [39] . Regarding chemokine ligands, CXCL1, CXCL2, and CXCL8 are recognized as important CXC chemokines in both experimental and clinical ALI. In our in vitro study, fasudil pretreatment significantly inhibited the overexpressions of CXCL1, CXCL2, and CXCL8 in LPS-challenged human PMECs, and attenuated neutrophil chemotaxis in a non-contact transwell coculture system. These results implicated that inhibiting ROCK by fasudil could prevent endothelial-mediated inflammation via suppressing inflammatory cell chemotaxis. In addition, in a contact coculture system, fasudil inhibited neutrophil adhesion to LPS-stimulated human PMECs. Since ICAM-1 promotes neutrophil-endothelial adhesion, this effect may be attributed to the downregulation of ICAM-1 in LPS-challenged human PMECs by fasudil. Consistently, it has been reported that ROCK regulated ICAM-1expression by virtue of controlling the downstream NF-κB signaling in endothelial-mediated inflammation [40, 41] . Together, attenuating endothelial cell inflammation could be one of the mechanisms for fasudil to prevent LPS-induced ALI.
It is well established that NF-κB pathway is engaged in endothelial barrier dysfunction in LPS-induced lung injury. Pharmacological inhibition of NF-κB activation suppressed LPS-induced apoptosis, cytokine release, and adhesion molecule expression in endothelial cells in vitro, and alleviated LPS-induced ALI in vivo [42] . Thus, NF-κB signaling was examined to elucidate the potential molecular mechanism underlying the protective effects of fasudil in LPS-induced endothelial dysfunction. Our results showed that LPS resulted in NF-κB activation in human PMECs, as indicated by pronounced phosphorylation of iκκαβ and NF-κB p65, as well as nuclear translocation of p65. However, these effects were suppressed by the selective ROCK inhibitor fasudil. Although whether the effects of fasudil are mediated by acting on NF-κB directly is unknown, it is well documented that ROCK is involved in NF-κB activation in endothelial cell during inflammation [41, 43] . Two isoforms of ROCK have been described and are widely referred to as ROCK1 and ROCK2. By using small interfering RNA-facilitated knockdown of each isoform, Shimada et al. identified ROCK2 activation as being the early event driving NF-κB activation and the subsequent transcriptional upregulation of chemokines and ICAM-1 in human endothelial cells treated with proinflammatory lysophosphatidic acid [43] . By using pharmacological approaches, Anwar et al. demonstrated that ROCK1 mediated thrombin-induced NF-κB activation in endothelial cells by enhancing phosphorylation of the transactivation domain of RelA/p65 [41] . In our study, fasudil potently inhibited LPS-induced upregulation of both ROCK1 and ROCK2, and downstream phosphorylation of MYPT-1 in human PMECs. Thereby, as discussed above, it is reasonable that fasudil could attenuate LPS-induced endothelial dysfunction through inactivation of ROCK-dependent NF-κB pathway.
In addition to NF-κB, MAPKs signaling pathways, including p38, ERK1/2, and JNK, also participate in LPS-induced endothelial injury [44] . It is noteworthy that these three kinases may have different functions in LPS-induced endothelial barrier dysfunction. Exactly, p38 activation critically contributes to endothelial apoptosis, cytokines and chemokines production, and ICAM-1 expression, while JNK activation mainly mediates endothelial apoptosis. The activation of ERK1/2 in response to LPS has not been well characterized. Several reports implicate that ERK1/2 regulates endothelial inflammation, apoptosis, and cell proliferation in response to LPS challenge. In the present study, we found that LPS challenge for 30 min induced a significant phosphorylation of both p38 and JNK, but only a moderate phosphorylation of ERK1/2 in human PMECs. This discrepancy may be attributed to their distinctive spatiotemporal activation patterns. In rat PMECs, it was reported that LPS could elicit an early and robust activation of p38 and JNK with the peak value at 30 min after treatment, while the activation of ERK1/2 reached the peak at 60 min [18] . Additionally, we found that pretreated with fasudil significantly inhibited LPS-induced activation of p38 in human PMECs, but had no significant effect on the activation of JNK and ERK1/2. By using fasudil, the relationship between ROCK and MAPKs has been investigated in various cells [18, 45, 46] suggesting that ROCK may regulate MAPKs signal transduction in a time-or cell-specific manner. In terms of the current study, our results suggest that p38, but not JNK or ERK1/2 might serve as the early downstream molecules of ROCK signal pathway in human PMEC dysfunction induced by LPS. 
Materials and Methods
Animal model of ALI
Lung histological examination
The left lung tissues were stained with Hematoxylin-and-eosin (H&E). For each section, a minimum of 10 randomly chosen areas were analyzed by microscopy (Laica, Germany) at 200 magnification. The degree of lung injury was assessed by a semi-quantitative scoring system depending on previous investigators [19] . 
Permeability of Evans blue dye
Lung permeability was examined as described by Long et al. [47] . In brief, mice were intraperitoneally injected with 20 mg/kg 1% Evans blue (EB) dye (containing 4% bovine serum albumin) 4 h prior to sacrifice. After animals were killed, the flushed lungs were photographed and entire lungs were weighted and frozen in liquid nitrogen. Then they were homogenized in formamide (1ml/100mg lung) and incubated for 24 h at 37°C. Homogenates were clarified by centrifugation at 12,000 g for 20 min and the absorbance of 200 μl clarified supernatant for each sample was measured at 620nm in a 96-well plate.
Cell Culture
Human PMECs were purchased from Sciencell Research Laboratories (Carlsbad, CA, USA). Cells were cultured at 37°C with 5% CO2 in EGM (Sciencell, USA) containing 1% penicillin, streptomycin, endothelial cell growth factors and 5% fetal bovine serum (Sciencell, USA). Cells between passage 4 to 6 were used for all experiments. After starvation for 6 h, cells were exposed to LPS (1 μg/ml) with or without fasudil (1 μg/ml) and further cultured for indicated time intervals. 
Statistical analysis
Values were expressed as mean ± SEM. Differences among multiple groups were determined by one-way ANOVA analysis followed by LSD. P < 0.05 was considered statistically significant. All in vitro independent experiments were repeated more than three times.
Conclusions
our studies suggest fasudil attenuates LPS-induced ALI through protecting endothelial cells from apoptosis, decreasing endothelial hyperpermeability and suppressing endothelial-mediated inflammation. These effects of fasudil could be attributed to the inhibition of ROCK and its downstream NF-κB and p38 signaling pathways. Our data also indicates that ROCK may be a promising target for blocking the progression of sepsis-or infection-related ALI. However, it should be mentioned here that this study only explored the prophylactic effects of fasudil in LPS-induced ALI. Whether fasudil has therapeutic effects in an established model of ALI requires further investigation. 
